Aotea News May 2010

Access the articles from Aotea News, May 2010, below.

The value of pathology 

Welcome to this first edition of Aotea News in its refreshing, new format.

In many ways, this new Aotea News is much like our mission here at Aotea Pathology: to provide a quality pathology service that is accessible, sustainable and of value to all. Read more here.

Computer-assisted screening of cervical smears approved

Aotea Pathology is delighted to announce it has approval from the National Cervical Screening Programme to begin computer-assisted screening of cervical smears. Read more here.

Latest update on guidelines for high-risk hpv testing

The referrer should request HrHPV on women with recent colposcopic treatment of high grade squamous lesions (within the past three years), or with historical high grade squamous lesions (more than three years), treated or not treated colposcopically. Read more here.

Giardia/crypto testing changes

For children under the age of six or for liquid stool specimens, we no longer routinely add on a Giardia/ Cryptosporidia antigen test on faecal specimens. Testing will be performed only where the referring clinician has requested it. Read more here.

Trichomonas testing -- new improved technique

We have recently introduced a new method of testing trichomonas in vaginal specimens. This involves culturing of Trichomonads and is regarded as the “Gold Standard” method. Read more here.

Vitamin D supplements will help reduce bone loss, fractures and disease

Aotea Pathology and doctors generally are concerned by evidence showing widespread vitamin D deficiency in people in New Zealand. For older people this is contributing to bone loss and consequent fractures, and in the general population there may be increased risk of a range of serious diseases.

Our advice is that providing vitamin D supplements is a safe, cost-effective and, indeed, necessary treatment. Read more here.

Testing for suspected venous thromboemblism

Venous thrombi are composed of red blood cells and fibrin, and form at areas of slow blood flow with low shearing forces.

D-dimers are the breakdown products of the fibrin clot, and a negative D-dimer assay (<500ng/mL) can be used to rule out the presence of venous thromboembolism. Read more here.

Quantiferon-TB Gold test

Aotea Pathology now offers the QuantiFERON-TB gold test for all employment-related TB screening, and for testing health sector students before clinical placements. Read more here.

Download the PDF

Download the PDF of this edition of Aotea News.